NCT07246928

Brief Summary

Ultrasound-guided Intralesional Injection of Cystic Hygroma - A Case Report

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 6, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 19, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 24, 2025

Completed
Last Updated

April 30, 2026

Status Verified

October 1, 2025

Enrollment Period

1 year

First QC Date

November 19, 2025

Last Update Submit

April 26, 2026

Conditions

Intralesional Injection of Cystic HygromaCystic Hygroma (Macro-cystic Lymphatic Malformation)

Outcome Measures

Primary Outcomes (2)

  • improvement: change in lesion size

    reduction in lesion size

    one year

  • improvement: reduction of lesion size

    one year

Study Arms (1)

pediatric patient

EXPERIMENTAL
Procedure: Intralesional Injection of Bleomycin

Interventions

Intralesional Injection of BleomycinPROCEDURE

Aspiration of Cystic Hygroma Fluid and Intralesional Injection

pediatric patient

Eligibility Criteria

Age1 Month - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Pediatric patients of age up to 12 years having cystic hygromas (macrocystic lymphatic malformations), from the vascular anomalies clinic at the pediatric surgery department in Cairo University Specialized Pediatric Hospital (Abu EL-Reesh hospital). -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Specialized Pediatric Hospital (Abu EL-Reesh Japanese hospital)

Cairo, Cairo Governorate, 12613, Egypt

Location

Related Links

MeSH Terms

Conditions

Lymphangioma, Cystic

Condition Hierarchy (Ancestors)

LymphangiomaNeoplasm, Lymphatic TissueNeoplasms by Histologic TypeNeoplasms

Study Officials

  • Gamal El-Tagy, MD

    pediatric surgery department, Cairo University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Case Report
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Oral and Maxillofacial Surgery, Faculty of Oral and Dental Medicine, Delta University for Science & Technology

Study Record Dates

First Submitted

November 19, 2025

First Posted

November 24, 2025

Study Start

September 1, 2024

Primary Completion

September 1, 2025

Study Completion

October 6, 2025

Last Updated

April 30, 2026

Record last verified: 2025-10

Locations

EG(1)